Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer, Blood, vol.105, issue.4, pp.1424-1430, 2005. ,
DOI : 10.1182/blood-2004-06-2501
Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors, Molecular Therapy, vol.13, issue.5, pp.967-975, 2006. ,
DOI : 10.1016/j.ymthe.2005.12.001
Treatment of human disease by adeno-associated viral gene transfer, Human Genetics, vol.5, issue.2, pp.571-603, 2006. ,
DOI : 10.1111/j.1349-7006.2002.tb01262.x
Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy, Blood, vol.113, issue.4, pp.797-806, 2009. ,
DOI : 10.1182/blood-2008-10-181479
Muscle-Directed Gene Transfer and Transient Immune Suppression Result in Sustained Partial Correction of Canine Hemophilia B Caused by a Null Mutation, Molecular Therapy, vol.4, issue.3, pp.192-200, 2001. ,
DOI : 10.1006/mthe.2001.0442
Lack of an Immune Response against the Tetracycline-Dependent Transactivator Correlates with Long-Term Doxycycline-Regulated Transgene Expression in Nonhuman Primates after Intramuscular Injection of Recombinant Adeno-Associated Virus, Journal of Virology, vol.76, issue.22, pp.11605-11611, 2002. ,
DOI : 10.1128/JVI.76.22.11605-11611.2002
Autoimmune anemia in macaques following erythropoietin gene therapy, Blood, vol.103, issue.9, pp.3303-3304, 2004. ,
DOI : 10.1182/blood-2003-11-3845
Erythropoietin gene therapy leads to autoimmune anemia in macaques, Blood, vol.103, issue.9, pp.3300-3302, 2004. ,
DOI : 10.1182/blood-2003-11-3852
Correction of Feline Lipoprotein Lipase Deficiency with Adeno-Associated Virus Serotype 1-Mediated Gene Transfer of the Lipoprotein Lipase S447X Beneficial Mutation, Human Gene Therapy, vol.17, issue.5, pp.487-499, 2006. ,
DOI : 10.1089/hum.2006.17.487
CD8+ T-cell responses to adeno-associated virus capsid in humans, Nature Medicine, vol.12, issue.4, pp.419-422, 2007. ,
DOI : 10.1038/nm1549
AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells, Blood, vol.114, issue.10, pp.2077-2086, 2009. ,
DOI : 10.1182/blood-2008-07-167510
Adenovirus-Associated Virus Vector???Mediated Gene Transfer in Hemophilia B, New England Journal of Medicine, vol.365, issue.25, pp.2357-2365, 2011. ,
DOI : 10.1056/NEJMoa1108046
The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver, Blood, vol.117, issue.24, pp.6459-6468, 2011. ,
DOI : 10.1182/blood-2010-10-314518
Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia B, Journal of Translational Medicine, vol.12, issue.1, p.25, 2014. ,
DOI : 10.1038/mt.2012.277
Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer, Journal of Clinical Investigation, vol.111, issue.9, pp.1347-1356, 2003. ,
DOI : 10.1172/JCI200316887
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver, Blood, vol.110, issue.7, pp.2334-2341, 2007. ,
DOI : 10.1182/blood-2007-03-080093
Lack of Immunotoxicity After Regional Intravenous (RI) Delivery of rAAV to Nonhuman Primate Skeletal Muscle, Molecular Therapy, vol.18, issue.1, pp.151-160, 2010. ,
DOI : 10.1038/mt.2009.251
Immediate and Long-Term Safety of Recombinant Adeno-associated Virus Injection into the Nonhuman Primate Muscle, Molecular Therapy, vol.4, issue.6, pp.559-566, 2001. ,
DOI : 10.1006/mthe.2001.0494
Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1, Blood, vol.103, issue.1, pp.85-92, 2004. ,
DOI : 10.1182/blood-2003-05-1446
Major role of local immune responses in antibody formation to factor IX in AAV gene transfer, Gene Therapy, vol.246, issue.19, pp.1453-1464, 2005. ,
DOI : 10.1128/JVI.78.6.3110-3122.2004
Impact of Pre-Existing Immunity on Gene Transfer to Nonhuman Primate Liver with Adeno-Associated Virus 8 Vectors, Human Gene Therapy, vol.22, issue.11, pp.1389-1401, 2011. ,
DOI : 10.1089/hum.2011.031
Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal Muscle, Molecular Therapy, vol.16, issue.7, pp.1291-1299, 2008. ,
DOI : 10.1038/mt.2008.87
Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs, Molecular Therapy, vol.18, issue.7, pp.1318-1329, 2010. ,
DOI : 10.1038/mt.2010.73
Adeno-Associated Virus Type 2-Mediated Transduction of Human Monocyte-Derived Dendritic Cells: Implications for Ex Vivo Immunotherapy, Journal of Virology, vol.75, issue.19, pp.9493-9501, 2001. ,
DOI : 10.1128/JVI.75.19.9493-9501.2001
Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self-cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loading of dendritic cells, Cancer Gene Therapy, vol.62, issue.3, pp.304-312, 2005. ,
DOI : 10.1165/ajrcmb.16.3.9070619
Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands, Gene Therapy, vol.176, issue.1, pp.29-39, 2006. ,
DOI : 10.1084/jem.176.6.1693
Induction of Robust Immune Responses against Human Immunodeficiency Virus Is Supported by the Inherent Tropism of Adeno-Associated Virus Type 5 for Dendritic Cells, Journal of Virology, vol.80, issue.24, pp.11899-11910, 2006. ,
DOI : 10.1128/JVI.00890-06
Major Subsets of Human Dendritic Cells Are Efficiently Transduced by Self-Complementary Adeno-Associated Virus Vectors 1 and 2, Journal of Virology, vol.81, issue.10, pp.5385-5394, 2007. ,
DOI : 10.1128/JVI.02516-06
Transduction Efficiency and Immune Response Associated With the Administration of AAV8 Vector Into Dog Skeletal Muscle, Molecular Therapy, vol.17, issue.1, pp.73-80, 2009. ,
DOI : 10.1038/mt.2008.225
Self-complementary AAVs Induce More Potent Transgene Product-specific Immune Responses Compared to a Single-stranded Genome, Molecular Therapy, vol.20, issue.3, pp.572-579, 2012. ,
DOI : 10.1038/mt.2011.280
Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers, J Virol, vol.72, pp.4212-4223, 1998. ,
CD40 Ligand-Dependent Activation of Cytotoxic T Lymphocytes by Adeno-Associated Virus Vectors In Vivo: Role of Immature Dendritic Cells, Journal of Virology, vol.74, issue.17, pp.8003-8010, 2000. ,
DOI : 10.1128/JVI.74.17.8003-8010.2000
Continuous CD8+ T-Cell Priming by Dendritic Cell Cross-Presentation of Persistent Antigen following Adeno-Associated Virus-Mediated Gene Delivery, Journal of Virology, vol.85, issue.22, pp.12083-12086, 2011. ,
DOI : 10.1128/JVI.05375-11
Prolonged Gene Expression in Muscle Is Achieved Without Active Immune Tolerance Using MicrorRNA 142.3p-Regulated rAAV Gene Transfer, Human Gene Therapy, vol.24, issue.4, pp.393-405, 2013. ,
DOI : 10.1089/hum.2012.208
Mir-142-3p target sequences reduce transgene-directed immunogenicity following intramuscular adeno-associated virus 1 vector-mediated gene delivery, The Journal of Gene Medicine, vol.18, issue.6-7, pp.219-232, 2013. ,
DOI : 10.1038/gt.2010.157
Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors, Proceedings of the National Academy of Sciences, vol.17, issue.6, pp.17158-17162, 2009. ,
DOI : 10.1089/hum.2006.17.625
AAV8 Induces Tolerance in Murine Muscle as a Result of Poor APC Transduction, T Cell Exhaustion, and Minimal MHCI Upregulation on Target Cells, Molecular Therapy, vol.22, issue.1 ,
DOI : 10.1038/mt.2013.134
Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart, Nature Biotechnology, vol.49, issue.3, pp.321-328, 2005. ,
DOI : 10.1128/JVI.76.2.791-801.2002
The recirculation of lymphocytes from blood to lymph in the rat, The Journal of Physiology, vol.146, issue.1, pp.54-69, 1959. ,
DOI : 10.1113/jphysiol.1959.sp006177
Quantification of lymph node transit times reveals differences in antigen surveillance strategies of naive CD4+ and CD8+ T cells, Proceedings of the National Academy of Sciences, vol.35, issue.6 ,
DOI : 10.1016/j.immuni.2011.10.017
The integration of T cell migration, differentiation and function, Nature Reviews Immunology, vol.1, issue.5, pp.309-320, 2013. ,
DOI : 10.1038/mi.2007.9
IFN-gamma influences the migration of thoracic duct B and T lymphocyte subsets in vivo. Random increase in disappearance from the blood and differential decrease in reappearance in the lymph, J Immunol, vol.150, pp.3843-3852, 1993. ,
Lymphocyte traffic through lymph nodes and Peyer's patches of the rat: B- and T-cell-specific migration patterns within the tissue, and their dependence on splenic tissue, Cell & Tissue Research, vol.20, issue.3, pp.377-386, 1995. ,
DOI : 10.1007/BF00318870
Stable transduction of quiescent CD34+CD38- human hematopoietic cells by HIV-1-based lentiviral vectors, Proceedings of the National Academy of Sciences, vol.91, issue.4, pp.2988-2993, 1999. ,
DOI : 10.1084/jem.188.6.1117
Cells That Mediate Long-Term Engraftment of NOD/SCID Mice by HIV Vectors, Science, vol.73, issue.5402, pp.682-686, 1999. ,
DOI : 10.1038/nbt0997-871
Marking and Gene Expression by a Lentivirus Vector in Transplanted Human and Nonhuman Primate CD34+ Cells, Journal of Virology, vol.74, issue.3, pp.1286-1295, 2000. ,
DOI : 10.1128/JVI.74.3.1286-1295.2000
High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors, Blood, vol.96, pp.3392-3398, 2000. ,
Complement Is an Essential Component of the Immune Response to Adeno-Associated Virus Vectors, Journal of Virology, vol.82, issue.6, pp.2727-2740, 2008. ,
DOI : 10.1128/JVI.01990-07
Immunity to adeno-associated virus vectors in animals and humans: a continued challenge, Gene Therapy, vol.2007, issue.11, pp.808-816, 2008. ,
DOI : 10.1182/asheducation-2007.1.466
APOBEC3A Is a Potent Inhibitor of Adeno-Associated Virus and Retrotransposons, Current Biology, vol.16, issue.5, pp.480-485, 2006. ,
DOI : 10.1016/j.cub.2006.01.031
Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis, Gene Therapy, vol.72, issue.16, pp.1248-1254, 2001. ,
DOI : 10.1016/0006-8993(95)01488-8
Liver Transplant Tolerance and Its Application to the Clinic: Can We Exploit the High Dose Effect?, Clinical and Developmental Immunology, vol.64, issue.10, p.419692, 2013. ,
DOI : 10.1006/smim.2000.0253
Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy, Blood, vol.99, issue.8, pp.2670-2676, 2002. ,
DOI : 10.1182/blood.V99.8.2670
Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells, Proceedings of the National Academy of Sciences, vol.299, issue.5609 ,
DOI : 10.1126/science.1079490
Bioluminescent virion shells: new tools for quantitation of AAV vector dynamics in cells and live animals, Gene Therapy, vol.5, issue.24, pp.1618-1622, 2008. ,
DOI : 10.1016/j.ymthe.2005.11.007
Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models, Molecular Therapy, vol.11, issue.6, pp.875-888, 2005. ,
DOI : 10.1016/j.ymthe.2004.12.022
Large-Scale Molecular Characterization of Adeno-Associated Virus Vector Integration in Mouse Liver, Journal of Virology, vol.79, issue.6, pp.3606-3614, 2005. ,
DOI : 10.1128/JVI.79.6.3606-3614.2005
Performance of AAV8 vectors expressing human factor IX from a hepatic-selective promoter following intravenous injection into rats, Genetic Vaccines and Therapy, vol.6, issue.1, p.9, 2008. ,
DOI : 10.1186/1479-0556-6-9
Nonviral-Mediated Hepatic Expression of IGF-I Increases Treg Levels and Suppresses Autoimmune Diabetes in Mice, Diabetes, vol.62, issue.2, pp.551-560, 2013. ,
DOI : 10.2337/db11-1776
In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance, Blood, vol.114, issue.25, pp.5152-5161, 2009. ,
DOI : 10.1182/blood-2009-04-214569
Liver-directed gene expression using recombinant AAV 2/8 vectors?a tolerogenic strategy for gene delivery, Discov Med, vol.9, pp.519-527, 2010. ,
Successful Interference with Cellular Immune Responses to Immunogenic Proteins Encoded by Recombinant Viral Vectors, Journal of Virology, vol.75, issue.1, pp.269-277, 2001. ,
DOI : 10.1128/JVI.75.1.269-277.2001
Induction of antitumor immunity using bone marrow-generated dendritic cells, J Immunol, vol.156, pp.2918-2926, 1996. ,
Complexity of immune responses to AAV transgene products ? Example of factor IX. Cellular Immunology, 2017. ,
Regulatory and Exhausted T Cell Responses to AAV Capsid, Human Gene Therapy, vol.284, pp.338-349, 2017. ,
Gene Editing and Germ-line Intervention: The Need for Novel Responses to Novel Technologies, Molecular Therapy, vol.23, issue.11, pp.1678-1680, 2015. ,
DOI : 10.1038/mt.2015.185
Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 Vectors, Molecular Therapy, vol.23, issue.6, pp.1022-1033, 2015. ,
DOI : 10.1038/mt.2015.59